SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 535 filers reported holding SEAGEN INC in Q3 2022. The put-call ratio across all filers is 0.33 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $64,353,491 | +9.6% | 303,339 | -0.6% | 0.02% | +10.5% |
| Q2 2023 | $58,737,724 | -4.7% | 305,201 | +0.3% | 0.02% | -9.5% |
| Q1 2023 | $61,625,204 | +159068.3% | 304,363 | +1.0% | 0.02% | +90.9% |
| Q4 2022 | $38,717 | -99.9% | 301,278 | +0.3% | 0.01% | -31.2% |
| Q3 2022 | $41,112,000 | -22.5% | 300,467 | +0.2% | 0.02% | -15.8% |
| Q2 2022 | $53,079,000 | +23.4% | 299,967 | +0.4% | 0.02% | +46.2% |
| Q1 2022 | $43,025,000 | -1.3% | 298,711 | +5.9% | 0.01% | 0.0% |
| Q4 2021 | $43,596,000 | -5.9% | 281,962 | +3.3% | 0.01% | -13.3% |
| Q3 2021 | $46,354,000 | +10.1% | 273,065 | +2.4% | 0.02% | +15.4% |
| Q2 2021 | $42,100,000 | +14.6% | 266,651 | +1.0% | 0.01% | +8.3% |
| Q1 2021 | $36,727,000 | -19.7% | 264,135 | +1.2% | 0.01% | -29.4% |
| Q4 2020 | $45,738,000 | – | 261,057 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $6,419,005,000 | 42.04% |
| Ally Bridge Group (NY) LLC | 92,506 | $12,658,000 | 8.36% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 166,200 | $22,739,000 | 7.29% |
| Eagle Health Investments LP | 174,902 | $23,932,000 | 5.49% |
| Avoro Capital Advisors LLC | 1,865,000 | $255,188,000 | 4.71% |
| Lagoda Investment Management, L.P. | 47,955 | $6,562,000 | 4.67% |
| Nan Fung Group Holdings Ltd | 47,096 | $6,444,000 | 4.11% |
| Ikarian Capital, LLC | 150,000 | $20,525,000 | 4.09% |
| Antara Capital LP | 946,100 | $129,455,000 | 3.42% |
| SECTOR GAMMA AS | 84,730 | $11,594,000 | 2.99% |